ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

RFA/PA/Drug Group Announcement Limited

May 6, 1988

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004